Search Results - "Lee, Hanna J."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Permanent hypothyroidism following immune checkpoint inhibitors induced thyroiditis may be associated with improved survival: results of an exploratory study by Lee, Hanna J, Manavalan, Anjali, Stefan-Lifshitz, Mihaela, Schechter, Clyde, Maity, Aloke, Tomer, Yaron

    Published in Frontiers in endocrinology (Lausanne) (19-04-2023)
    “…Immune-related endocrinopathies are common after immune checkpoint inhibitor (ICI) therapy, among which destructive thyroiditis is the most prevalent. Improved…”
    Get full text
    Journal Article
  2. 2

    Severe Hyponatremia Triggered by Immune Checkpoint Inhibitor Therapy in a Patient With Mulvihill-Smith Syndrome by Tavdy, Tammy, Samavedam, Janaki Manasa, Mathias, Priyanka, Lee, Hanna J.

    Published in AACE clinical case reports (01-05-2024)
    “…Immune checkpoint inhibitors (ICI), including Programmed Cell Death 1, Programmed Cell Death Ligand 1, and Cytotoxic T-lymphocyte Associated Antigen 4…”
    Get full text
    Journal Article
  3. 3

    Immunogenetics of autoimmune thyroid diseases: A comprehensive review by Lee, Hanna J, Li, Cheuk Wun, Hammerstad, Sara Salehi, Stefan, Mihaela, Tomer, Yaron

    Published in Journal of autoimmunity (01-11-2015)
    “…Abstract Both environmental and genetic triggers factor into the etiology of autoimmune thyroid disease (AITD), including Graves' disease (GD) and Hashimoto's…”
    Get full text
    Journal Article
  4. 4

    Genetics and epigenetics of autoimmune thyroid diseases: Translational implications by Lee, Hanna J., Stefan–Lifshitz, Mihaela, Li, Cheuk Wun, Tomer, Yaron

    “…Hashimoto's thyroiditis (HT) and Graves' disease (GD) are prevalent autoimmune disorders, representing opposite ends of the clinical spectrum of autoimmune…”
    Get full text
    Journal Article
  5. 5

    Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion by Lee, Hanna J, Sajan, Alen, Tomer, Yaron

    Published in Journal of the Endocrine Society (01-11-2021)
    “…Abstract Context Hyperglycemic emergencies such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) and new-onset diabetes mellitus…”
    Get full text
    Journal Article
  6. 6

    Diabetes and Hepatitis C: A Two-Way Association by Hammerstad, Sara Salehi, Grock, Shira Frankel, Lee, Hanna J, Hasham, Alia, Sundaram, Nina, Tomer, Yaron

    Published in Frontiers in endocrinology (Lausanne) (14-09-2015)
    “…Diabetes and hepatitis C infection are both prevalent diseases worldwide, and are associated with increased morbidity and mortality. Most studies, but not all,…”
    Get full text
    Journal Article
  7. 7

    CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation by Lee, Hanna J., Lombardi, Angela, Stefan, Mihaela, Li, Cheuk wun, Inabnet, William B., Owen, Randall P., Concepcion, Erlinda, Tomer, Yaron

    Published in Endocrinology (Philadelphia) (01-02-2017)
    “…Abstract CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other…”
    Get full text
    Journal Article
  8. 8

    HEPATITIS C VIRUS E2 PROTEIN INDUCES UPREGULATION OF IL-8 PATHWAYS AND PRODUCTION OF HEAT SHOCK PROTEINS IN HUMAN THYROID CELLS by Hammerstad, Sara Salehi, Stefan, Mihaela, Blackard, Jason, Owen, Randall P, Lee, Hanna J, Concepcion, Erlinda, Yi, Zhengzi, Zhang, Weijia, Tomer, Yaron

    “…CONTEXT:Thyroiditis is one of the most common extra hepatic manifestations of hepatitis C virus infection. By binding to surface cell receptor CD81, hepatitis…”
    Get full text
    Journal Article
  9. 9

    RAPID EVOLUTION OF THYROID DYSFUNCTION IN PATIENTS TREATED WITH NIVOLUMAB by O'Malley, Grenye, Lee, Hanna J, Parekh, Samir, Galsky, Matthew D, Smith, Cardinale B, Friedlander, Philip, Yanagisawa, Robert T, Gallagher, Emily J

    Published in Endocrine practice (01-10-2017)
    “…To describe the evolution of thyroid dysfunction in a series of patients with cancer treated with the immune checkpoint inhibitor anti-programmed cell death…”
    Get more information
    Journal Article
  10. 10

    CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor [kappa]B Activation by Lee, Hanna J, Lombardi, Angela, Mihaela, Stefan, Li, Cheuk wun, Inabnet, William B, Owen, Randall P, Concepcion, Erlinda, Tomer, Yaron

    Published in Endocrinology (Philadelphia) (01-02-2017)
    “…Abstract CD40, a tumor necrosis factor receptor, is a major immune-modulating susceptibility gene for Graves disease (GD) as well as for a variety of other…”
    Get full text
    Journal Article
  11. 11

    Severe Hyponatremia Triggered by Immune Checkpoint Inhibitor Therapy in a Patient With Mulvihill-Smith Syndrome by Tavdy, Tammy, Samavedam, Janaki Manasa, Mathias, Priyanka, Lee, Hanna J

    Published in AACE clinical case reports (01-05-2024)
    “…Background/ObjectiveImmune checkpoint inhibitors (ICI), including Programmed Cell Death 1, Programmed Cell Death Ligand 1, and Cytotoxic T-lymphocyte…”
    Get full text
    Report
  12. 12

    Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion by Lee, Hanna J, Sajan, Alen, Tomer, Yaron

    Published in Journal of the Endocrine Society (01-11-2021)
    “…CONTEXTHyperglycemic emergencies such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) and new-onset diabetes mellitus (DM) have…”
    Get full text
    Report